These milestones highlight the growing regulatory and clinical momentum supporting expanded uses Ongoing trials are also exploring the impact of GLP-1 agonists on cardiovascular outcomes, liver health, and even neurodegenerative diseases, reinforcing their value in treating systemic metabolic disorders
The FDA approved synthetic HGH in 1985 for specific medical conditions, including growth hormone deficiency, Turner syndrome, chronic renal insufficiency, and muscle-wasting disease associated with HIV/AIDS
Some people may naturally be allergic to antiretroviral drugs, but paradoxically, having HIV or AIDS also increases a person's risk of developing allergies (per Drugs.com)
Many postpartum women face the challenge of managing weight while nursing, yet medication safety during lactation raises legitimate concerns
Parenteral Nutrition-associated liver complications in children
When it comes to skin, glutathione works on several interconnected levels